Raphael Pharmaceutical (RAPH) Short term Debt (2020 - 2025)
Raphael Pharmaceutical (RAPH) posted Short term Debt of $34000.0 for Q4 2025, down 17.07% sequentially from $41000.0 in Q3 2025, and down 17.07% YoY from $41000.0 in Q4 2024.
Raphael Pharmaceutical (RAPH) Short term Debt (2020 - 2025) Analysis & Trends
Raphael Pharmaceutical has reported Short term Debt for 5 years, with the latest figure at $34000.0 in Q4 2025.
- Quarterly Short term Debt fell 17.07% year-over-year to $34000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $34000.0 (down 17.07% YoY) and the FY2025 annual result came in at $34000.0, down 17.07% from the prior year.
- Short term Debt fell to $34000.0 in Q4 2025 per RAPH's latest filing, from $41000.0 in the prior quarter.
- Over five years, Short term Debt peaked at $41000.0 in Q4 2024 and troughed at $1000.0 in Q1 2022.
- A 4-year average of $26444.4 and a median of $34000.0 in 2025 frame the typical range for Short term Debt.
- The sharpest annual moves came in 2021 and 2022: Short term Debt surged 144.44% in 2021, then tumbled 86.36% in 2022.
- Over 4 years, Short term Debt stood at $22000.0 in 2021, then sank by 86.36% to $3000.0 in 2022, then jumped by 1266.67% to $41000.0 in 2024, then slipped by 17.07% to $34000.0 in 2025.
- According to Business Quant data, Short term Debt over the past three periods registered $34000.0, $41000.0, and $41000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Raphael Pharmaceutical | 28.25 Mn | 28.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 34,000.00 |
| Sep 30, 2025 | 41,000.00 |
| Jun 30, 2025 | 41,000.00 |
| Mar 31, 2025 | 41,000.00 |
| Dec 31, 2024 | 41,000.00 |
| Dec 31, 2022 | 3,000.00 |
| Jun 30, 2022 | 14,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Dec 31, 2021 | 22,000.00 |
| Dec 31, 2020 | 9,000.00 |